Ultragenyx Pharmaceutical | RARE - Eps Gewinn Pro Aktie

Aktienkurs
24.10
Täglich Wechseln
-0.18 -0.74%
Monatlich
21.41%
Jährlich
-36.73%
Q2 Prognose
23.58

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q1 Mar/2026 -1.43 -1.57 Apr/30
FY2025Q4 Dec/2025 -1.29 -1.17 -1.39 Feb/12
FY2025Q3 Sep/2025 -1.81 -1.23 -1.40 Nov/04
FY2025Q2 Jun/2025 -1.17 -1.29 -1.52 Aug/05
FY2025Q1 Mar/2025 -1.57 -1.53 -2.03 May/06




Eps Veränderung Datum
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
Agios Pharmaceuticals USD -1.86 0.08 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
BioCryst Pharmaceuticals USD 1.17 1.1 2025-12
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Esperion Therapeutics USD 0.26 0.42 2025-12
Immunic USD -0.24 0.03 2024-09
Insmed USD -1.54 0.21 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
Karyopharm Therapeutics USD -2.22 2.07 2025-12
Kyowa Hakko Kirin JPY 65.79 34.69 2025-12
MacroGenics USD -0.22 0.49 2025-12
Moderna USD -2.11 1.6 2025-12
Neurocrine Biosciences USD 1.88 0.29 2025-12
PTC Therapeutics USD -1.67 1.87 2025-12
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Sarepta Therapeutics USD -3.58 3.45 2025-12
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12
Xoma USD -1.59 2.43 2024-09